Literature DB >> 26307392

Malignant tumors of the uterine corpus: molecular background of their origin.

D Brany1, D Dvorska1, M Nachajova2, P Slavik3, T Burjanivova4.   

Abstract

Tumors of the uterine corpus can be divided into two main groups: endometrial tumors and mesenchymal tumors. The former ones are common gynecological diseases, whereas malignant mesenchymal tumors, which behave in a much more aggressive way, are quite rare with a poorer prognosis. The most common type of endometrial tumors is endometrioid adenocarcinomas, and in case of mesenchymal tumors, these are carcinosarcomas, or leiomyosarcomas, if only clear types of tumors are taken into account. The objective of this article is to review molecular-genetic abnormalities associated with tumorigenesis of both types of tumors, with focus on the most aggressive forms. This view includes a different expression pattern of genes, usually aberrant in cases of uterine cancer that can arise due to epigenetic modifications, mostly hypermethylation of promoters or microRNA (miRNA)'s interference with concrete genes. Furthermore, clinical predispositions of tumorigenesis, involving hormonal factors, age, and ethnicity, are also mentioned.

Entities:  

Keywords:  Endometrial cancer; Endometrium; Sarcoma; Uterine corpus tumors

Mesh:

Substances:

Year:  2015        PMID: 26307392     DOI: 10.1007/s13277-015-3824-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  69 in total

1.  Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.

Authors:  Nurcan Uluskan Ünver; Mustafa Fuat Acikalin; Ülkü Öner; Evrim Ciftci; S Sinan Ozalp; Ertugrul Colak
Journal:  Arch Gynecol Obstet       Date:  2010-09-28       Impact factor: 2.344

2.  Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Authors:  W-K Hofmann; S Takeuchi; N Takeuchi; E Thiel; D Hoelzer; H P Koeffler
Journal:  Leuk Res       Date:  2006-05-08       Impact factor: 3.156

3.  Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas.

Authors:  Khush Mittal; Alla Joutovsky
Journal:  Gynecol Oncol       Date:  2006-10-02       Impact factor: 5.482

4.  Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.

Authors:  George Jour; John D Scarborough; Robin L Jones; Elizabeth Loggers; Seth M Pollack; Colin C Pritchard; Benjamin L Hoch
Journal:  Hum Pathol       Date:  2014-04-24       Impact factor: 3.466

5.  Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer.

Authors:  Jozef Visnovsky; Erik Kudela; Anna Farkasova; Tomas Balharek; Milan Krkoska; Jan Danko
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

6.  Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study.

Authors:  Todd W Kelley; Ernest C Borden; John R Goldblum
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-12

7.  Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Authors:  Robert L Giuntoli; Daniel S Metzinger; Connie S DiMarco; Stephen S Cha; Jeff A Sloan; Gary L Keeney; Bobbie S Gostout
Journal:  Gynecol Oncol       Date:  2003-06       Impact factor: 5.482

8.  Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.

Authors:  Kouji Banno; Megumi Yanokura; Nobuyuki Susumu; Makiko Kawaguchi; Nobumaru Hirao; Akira Hirasawa; Katsumi Tsukazaki; Daisuke Aoki
Journal:  Oncol Rep       Date:  2006-12       Impact factor: 3.906

Review 9.  Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.

Authors:  D Llobet; J Pallares; A Yeramian; M Santacana; N Eritja; A Velasco; X Dolcet; X Matias-Guiu
Journal:  J Clin Pathol       Date:  2008-10-31       Impact factor: 3.411

10.  The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.

Authors:  Tsai-Der Chuang; Matthew Ho; Omid Khorram
Journal:  Reprod Sci       Date:  2014-10-09       Impact factor: 3.060

View more
  2 in total

1.  The risk of distant metastases in patients with gynecologic cancers after surgery: a population-based study.

Authors:  Yi-Hsuan Hsiao; Pei-Ni Chen; Min-Chien Hsin; Po-Hui Wang; Jing-Yang Huang; Shun-Fa Yang
Journal:  Aging (Albany NY)       Date:  2021-12-16       Impact factor: 5.682

2.  Mortality prediction in women with corpus uteri cancer in Brazil: a 21-year analysis.

Authors:  Diego Bessa Dantas; Lucio Flávio Garcia Rodrigues; Fabiana de Campos Gomes; João Simão de Melo-Neto
Journal:  Ecancermedicalscience       Date:  2020-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.